Gallium-68 (68Ga)-labelled PSMA is a safe, non-invasive imaging tracer commonly used in clinical imaging of prostate cancer and has demonstrated superior performance in localised and metastatic disease, as well as in early detection of disease recurrence compared to conventional imaging [37,38,39]. This evidence concerns the gene FOLH1 and prostate carcinoma.